Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus HA Odhar, SW Ahjel, AAMA Albeer, AF Hashim, AM Rayshan, SS Humadi Bioinformation 16 (3), 236, 2020 | 91 | 2020 |
Molecular docking enabled updated screening of the matrix protein VP40 from Ebola virus with millions of compounds in the MCULE database for potential inhibitors HA Odhar, AM Rayshan, SW Ahjel, AA Hashim, AAMA Albeer Bioinformation 15 (9), 627, 2019 | 26 | 2019 |
Computational Repurposing of FDA Approved Drugs Against Monkeypox Virus Cysteine Proteinase: A Molecular Docking and Dynamics Simulation Study. HA Odhar OSF Preprints, 2022 | 9 | 2022 |
Computational screening of FDA approved drugs from ZINC database for potential inhibitors of Zika Virus NS2B/NS3 protease: a molecular docking and dynamics simulation study HA Odhar, SW Ahjel, ZA Odhar Journal of Pharmaceutical Research International 33 (39B), 308-319, 2021 | 9 | 2021 |
Molecular docking and dynamics simulation analysis of nucleoprotein from the Crimea-Congo hemorrhagic fever virus strain Baghdad-12 with FDA approved drugs AF Hashim, HA Odhar, SW Ahjel Bioinformation 18 (5), 442, 2022 | 6 | 2022 |
Virtual Screening of FDA Approved Drugs Library to Identify a Potential Inhibitor against NS2B-NS3 Protease of Yellow Fever Virus HA Odhar, SW Ahjel, A Albeer, AF Hashim, SS Humadi J Pharm Res Int 33 (51B), 177-186, 2021 | 6 | 2021 |
Towards the design of epitope candidates for Coronavirus 2 HA Odhar, SW Ahjel, SS Humadi Bioinformation 16 (5), 375, 2020 | 6 | 2020 |
Molecular docking analysis and dynamics simulation of salbutamol with the monoamine oxidase B (MAO-B) enzyme HA Odhar, AF Hashim, SS Humad Bioinformation 18 (3), 304, 2022 | 5 | 2022 |
Molecular docking and dynamics simulation of a screening library from life chemicals database for potential protein-protein interactions (PPIs) inhibitors against SARS-CoV-2 … HA Odhar, SW Ahjel, AF Hashim, AM Rayshan Journal of Pharmaceutical Research International 33 (28), 74-84, 2021 | 5 | 2021 |
Exploration of potential link between prevalence of irritable bowel syndrome and seropositivity for Helicobacter pylori HA Odhar, AF Hashim, DH Obaid, RS Majeed, OA Habeeb, ... Indian Journal of Public Health 10 (10), 2915, 2019 | 5 | 2019 |
Molecular docking and dynamics simulation analysis of the human FXIIa with compounds from the Mcule database HA Odhar, AF Hashim, SW Ahjel, SS Humadi Bioinformation 19 (2), 160, 2023 | 2 | 2023 |
Design and construction of multi epitope-peptide vaccine candidate for rabies virus HA Odhar, AF Hashim, SS Humadi, SW Ahjel Bioinformation 19 (2), 167, 2023 | 2 | 2023 |
Towards the design of multiepitope-based peptide vaccine candidate against SARS-CoV-2 HA Odhar, SW Ahjel, SS Humadi BioRxiv, 2020.07. 07.186122, 2020 | 2 | 2020 |
A case of primary endometriosis associated with an umbilical hernia ZA Odhar, MR Muhi, HA Odhar, Z Odhar, M Muhi Cureus 14 (8), 2022 | 1 | 2022 |
Potential Trends for COVID-19 Fighting: An Immuno-informatics Overview HA Odhar, SW Ahjel OSF Preprints, 2020 | 1 | 2020 |
Clarifying the Relationship of Serum Levels of Iron and Copper with Type 2 Diabetes Mellitus MA Hasan, SW Ahjel, HA Odhar, RM Hussein, MRA Alhaideri Indian Journal of Forensic Medicine & Toxicology 13 (4), 888, 2019 | 1 | 2019 |
Identification of novel scaffolds for Monoamine oxidase B inhibitors H Odhar Kent State University, 2014 | 1 | 2014 |
Molecular docking, dynamics and in vitro analysis of multi-target inhibitors for Clostridioides difficile NC Golchha, HA Odhar, A Nighojkar, S Nighojkar Bioinformation 20 (1), 39, 2024 | | 2024 |
VIRTUAL SCREENING OF FDA-APPROVED DRUGS BY MOLECULAR DOCKING AND DYNAMICS SIMULATION TO RECOGNIZE POTENTIAL INHIBITORS AGAINST MYCOBACTERIUM TUBERCULOSIS ENOYL-ACYL CARRIER … HA ODHAR, AF HASHIM, SW AHJEL, SS HUMADI Int J App Pharm 16 (1), 261-266, 2024 | | 2024 |
LIGAND-BASED VIRTUAL SCREENING OF FDA-APPROVED DRUGS TO IDENTIFY NEW INHIBITORS AGAINST LACTATE DEHYDROGENASE ENZYME OF MALARIA PARASITES HA ODHAR, AF HASHIM, SS HUMADI, SW AHJEL Int J App Pharm 16 (1), 255-260, 2024 | | 2024 |